Lynn Dressler

625 total citations
9 papers, 426 citations indexed

About

Lynn Dressler is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Lynn Dressler has authored 9 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Lynn Dressler's work include HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Genomics and Diagnostics (3 papers). Lynn Dressler is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Genomics and Diagnostics (3 papers). Lynn Dressler collaborates with scholars based in United States, Australia and United Kingdom. Lynn Dressler's co-authors include Donald A. Berry, Gloria Broadwater, Daniel F. Hayes, Ann D. Thor, Helena Furberg, Joseph Geradts, Hyman B. Muss, Larry Norton, D. R. Budman and Edison T. Liu and has published in prestigious journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment and Breast Cancer Research.

In The Last Decade

Lynn Dressler

8 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynn Dressler United States 6 355 223 112 110 63 9 426
A Ashfield United Kingdom 6 229 0.6× 186 0.8× 71 0.6× 144 1.3× 22 0.3× 10 351
G.P. Boland United Kingdom 7 224 0.6× 167 0.7× 138 1.2× 96 0.9× 69 1.1× 8 417
S. Ashley United Kingdom 6 340 1.0× 272 1.2× 48 0.4× 119 1.1× 47 0.7× 8 487
A Luisi Italy 8 285 0.8× 256 1.1× 72 0.6× 144 1.3× 24 0.4× 10 434
Monica Jernberg Engstrøm Norway 11 273 0.8× 242 1.1× 67 0.6× 147 1.3× 58 0.9× 21 472
J.C. Titley United Kingdom 9 249 0.7× 206 0.9× 85 0.8× 111 1.0× 28 0.4× 12 373
Matthieu Rupin United States 5 339 1.0× 328 1.5× 54 0.5× 81 0.7× 35 0.6× 7 444
LA Carey United States 12 439 1.2× 307 1.4× 45 0.4× 117 1.1× 62 1.0× 49 560
Tammy Robson United Kingdom 7 253 0.7× 198 0.9× 86 0.8× 95 0.9× 104 1.7× 12 343
Balvinder Shoker United Kingdom 10 260 0.7× 218 1.0× 159 1.4× 164 1.5× 21 0.3× 18 482

Countries citing papers authored by Lynn Dressler

Since Specialization
Citations

This map shows the geographic impact of Lynn Dressler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Dressler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Dressler more than expected).

Fields of papers citing papers by Lynn Dressler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Dressler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Dressler. The network helps show where Lynn Dressler may publish in the future.

Co-authorship network of co-authors of Lynn Dressler

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Dressler. A scholar is included among the top collaborators of Lynn Dressler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Dressler. Lynn Dressler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Harris, Lyndsay N., Gloria Broadwater, Maysa Abu‐Khalaf, et al.. (2009). Topoisomerase IIα Amplification Does Not Predict Benefit From Dose-Intense Cyclophosphamide, Doxorubicin, and Fluorouracil Therapy in HER2-Amplified Early Breast Cancer: Results of CALGB 8541/150013. Journal of Clinical Oncology. 27(21). 3430–3436. 38 indexed citations
2.
Harris, Lyndsay N., Gloria Broadwater, Nancy U. Lin, et al.. (2006). Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342. Breast Cancer Research. 8(6). 123 indexed citations
3.
Rincón, Mercedes, Gloria Broadwater, Lyndsay N. Harris, et al.. (2006). Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806. Breast Cancer Research and Treatment. 100(3). 301–308. 22 indexed citations
4.
Schilsky, Richard L., Lynn Dressler, Donna Bucci, et al.. (2002). Cooperative group tissue banks as research resources: the cancer and leukemia group B tissue repositories.. PubMed. 8(5). 943–8. 12 indexed citations
5.
Ambrosone, Christine B., Lynn Dressler, Helena Furberg, et al.. (2002). Environmental Factors in Relation to Breast Cancer characterized by P53 Protein Expression. 1 indexed citations
6.
Furberg, Helena, et al.. (2001). Tumor characteristics in African American and white women. Breast Cancer Research and Treatment. 68(1). 33–43. 79 indexed citations
7.
Berry, Donald A., Hyman B. Muss, Ann D. Thor, et al.. (2000). HER-2/neu and p53 Expression Versus Tamoxifen Resistance in Estrogen Receptor–Positive, Node-Positive Breast Cancer. Journal of Clinical Oncology. 18(20). 3471–3479. 146 indexed citations
8.
Wong, Gene K., et al.. (1996). Predictive value of flow cytometric analysis in DNA contents in patients with locally advanced head and neck carcinoma. The Journal of Laryngology & Otology. 110(3). 243–248. 4 indexed citations
9.
Dressler, Lynn, et al.. (1992). The use of dna flow cytometry to characterize breast cancer cells affected by presurgical neoadjuvant chemotherapy. 33. 213. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026